Author

G. V. Martinez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Assay:imaging· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. R. Jackson· 1 shared A. Rauckhorst· 1 shared A. Simoni· 1 shared B. G. Allen· 1 shared B. V. Jardim Perassi· 1 shared D. R. Reed· 1 shared D. R. Spitz· 1 shared D. Zepeda-Orozco· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. R. Jackson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tubular Mitochondrial Pyruvate Carrier Disruption Elicits Redox Adaptations that Protect from Acute Kidney Injury

A. Rauckhorst, G. V. Martinez, G. M. Andrade, H. Wen, J. Y. Kim, A. Simoni, K. A. Mapuskar, P. Rastogi, E. J. Steinbach, M. L. McCormick, B. G. Allen, A. R. Jackson, N. S. Pabla, M. C. Coleman, D. R. Spitz, , D. Zepeda-Orozco

The paper shows that reducing mitochondrial pyruvate carrier activity in kidney tubular cells protects against acute kidney injury by enhancing redox defenses and survival.

bioRxiv · Jan 31, 2023Biochemistry

Targeting hypoxic habitats with hypoxia pro-drug evofosfamide in preclinical models of sarcoma

B. V. Jardim Perassi, W. Mu, S. Huang, M. R. Tomaszewski, J. Poleszczuk, M. A. Abdalah, M. M. Budzevich, W. Dominguez-Viqueira, D. R. Reed, M. M. Bui, J. O. Johnson, G. V. Martinez, R. J. Gillies

This paper develops deep-learning models to identify hypoxic tumor regions using MRI and histology, showing their effectiveness in predicting hypoxia and guiding TH-302 therapy response in sarcoma models.

bioRxiv · Oct 6, 2020 · PreprintCancer Biology